Percutaneous endovenous treatment of congenital extratruncular venous malformations with an ultrasound-guided and 810-nm diode laser

Lu, Xinwu; Ye, Kaichuang; Shi, Huigang; Liu, Weimin; Huang, Ying; Huang, Xintian; Lü, Min; Jiang, Mier

doi:10.1016/j.jvs.2010.11.105

Cited by 27 publications

(27 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The immediate results indicated an excellent closure rate of 100% comparing favorably to other minimally invasive techniques. These results were confirmed by other groups [107,[110][111][112][113]. A study of the short-term efficacy of EVLT showed that 99% out of 90 cases still showed vessel closures after 9 months follow-up [107].…”

Section: Treatment Of Vascular Malformations and Hemangiomas With Diosupporting

confidence: 66%

Diode laser based light sources for biomedical applications

Müller

Marschall

Jensen

et al. 2012

Laser & Photonics Reviews

View full text Add to dashboard Cite

Diode lasers are by far the most efficient lasers currently available. With the ever-continuing improvement in diode laser technology, this type of laser has become increasingly attractive for a wide range of biomedical applications. Compared to the characteristics of competing laser systems, diode lasers simultaneously offer tunability, high-power emission and compact size at fairly low cost. Therefore, diode lasers are increasingly preferred in important applications, such as photocoagulation, optical coherence tomography, diffuse optical imaging, fluorescence lifetime imaging, and terahertz imaging. This review provides an overview of the latest development of diode laser technology and systems and their use within selected biomedical applications. 670 nm external cavity diode laser for Raman spectroscopy built on a 13 × 4 mm 2 microbench (Copyright FBH/Schurian.com).

show abstract

Section: Treatment Of Vascular Malformations and Hemangiomas With Diosupporting

confidence: 66%

Diode laser based light sources for biomedical applications

Müller

Marschall

Jensen

et al. 2012

Laser & Photonics Reviews

View full text Add to dashboard Cite

show abstract

“…Sidhu et al . and Lu et al . reported alleviation of pain in all 8 and 51 lesions in 6 and 33 patients, respectively.…”

Section: Resultsmentioning

confidence: 92%

Japanese clinical practice guidelines for vascular anomalies 2017

Mimura

Akita

Fujino

et al. 2020

Pediatrics International

View full text Add to dashboard Cite

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence‐based guidelines for the management of vascular anomalies.

show abstract

“…High laser energy levels can destroy the PTFE and Dacron fabrics completely, which might limit the potential ischemia time to <2 minutes during operations. The diode laser was used to treat superficial venous insufficiency and congenital extratruncular venous malformations, as we recently reported . The diode laser was developed to obtain a more selective action against blood vessels than previous lasers, which operate at wavelengths of 940 or 810 nm, with selective tertiary hemoglobin peak, and a depth of penetration in the blood of just 0.3 mm .…”

Section: Discussionmentioning

confidence: 99%

In Situ Laser Fenestration Is a Feasible Method for Revascularization of Aortic Arch During Thoracic Endovascular Aortic Repair

Qin

Zhao

Wang

et al. 2017

JAHA

Self Cite

View full text Add to dashboard Cite

BackgroundReconstruction of the aortic major branches during thoracic endovascular aortic repair is complicated because of the complex anatomic configuration and variation of the aortic arch. In situ laser fenestration has shown great potential for the revascularization of aortic branches. This study aims to evaluate the feasibility, effectiveness, and safety of in situ laser fenestration on the three branches of the aortic arch during thoracic endovascular aortic repair.Methods and ResultsBefore clinical application, the polytetrafluoroethylene and Dacron grafts were fenestrated by an 810‐nm laser system ex vivo, which did not damage the bare metal portion of the endografts and created a clean fenestration while maintaining the integrity of the endografts. In vivo, 6 anesthetized female swine survived after this operation, including stent‐graft implantation in the aortic arches, laser fenestration, and conduit implantation through the innominate arteries and the left carotid arteries. Based on the animal experiments, in situ laser fenestration during thoracic endovascular aortic repair was successively performed on 24 patients (aged 33–86 years) with aortic artery diseases (dissection type A: n=4, type B: n=7, aneurysm: n=2, mural thrombus: n=7). Fenestration of 3 aortic branches was performed in 2 (8.3%) patients. Both the left carotid artery and the left subclavian artery were fenestrated in 6 (25%) patients. Only left subclavian artery fenestration surgery was done in 16 (66.7%) patients. Among these patients, 1 fenestration was abandoned secondary to an acute takeoff of the innominate artery in a type III aortic arch. The average operative time was 137±15 minutes. The technical success rate was 95.8% (n=23). No fenestration‐related complications or neurological morbidity occurred after this operation. During a mean postoperative 10‐month follow‐up (range: 2–17 months), 1 patient died of severe pneumonia, and all the left subclavian artery and carotid artery stents were patent with no fenestration‐related endoleaks upon computed tomography angiography images.ConclusionsIn situ laser fenestration is a feasible, effective, rapid, repeatable, and safe option for the reconstruction of aortic arch during thoracic endovascular aortic repair, which might be available to revascularize the 3 branches. However, follow‐up periods should be extended to evaluate the robustness of this technique.

show abstract

Percutaneous endovenous treatment of congenital extratruncular venous malformations with an ultrasound-guided and 810-nm diode laser

Abstract: Treatment of congenital EVMs with endovenous laser ablation under US guidance achieved palliation in most symptomatic patients; it was safe, with minimal morbidity during short-term follow-up.

Cited by 27 publications

References 21 publications

Diode laser based light sources for biomedical applications

Diode laser based light sources for biomedical applications

Japanese clinical practice guidelines for vascular anomalies 2017

In Situ Laser Fenestration Is a Feasible Method for Revascularization of Aortic Arch During Thoracic Endovascular Aortic Repair

Contact Info

Product

Resources

About